Not Feeling Less Hungry on Mounjaro 5mg? Here's What the Evidence Says

The biggest misconception: 5mg should feel like the full effect

A question our prescribers hear most weeks is some version of: "I'm on 5mg and I still feel hungry, is the medicine not working?" The assumption behind it is understandable. But 5mg is not the dose at which Mounjaro's appetite effects are designed to peak. The licensed schedule starts at 2.5mg purely to let your body adjust to the medicine; 5mg is the second step in that process, not the destination.

Mounjaro (tirzepatide) works by activating two gut-hormone receptors simultaneously (GIP and GLP-1) which together slow gastric emptying and signal fullness to the brain. That dual action is what makes it the only medicine of its kind licensed in the UK for weight management. But the degree to which those signals translate into felt hunger suppression tends to grow as the dose increases. Clinical trial data published in the SURMOUNT-1 trial in the New England Journal of Medicine showed the largest weight reductions at the 10mg and 15mg doses, a pattern that reflects, in part, stronger appetite suppression at those levels.

Feeling broadly similar at 5mg to how you felt at 2.5mg is common. It does not mean the medicine is failing. It may mean you are not yet at the dose where your response becomes obvious.

What actually drives when the effect kicks in

Several factors shape whether 5mg produces noticeable appetite changes for a specific person. Gastric-emptying speed varies between individuals: people whose stomachs empty more quickly may feel the slowing effect less at lower doses. Habitual eating patterns matter too, if meals are governed more by schedule or social cues than by physical hunger, a reduction in hunger signals can be harder to detect in the first weeks.

Background diet plays a role as well. High-fat, high-sugar foods can partly override the satiety signalling these medicines promote. The NHS tirzepatide guidance notes that Mounjaro is licensed for use alongside a reduced-calorie diet and increased physical activity, not as a standalone intervention. That context matters: the appetite effect and the lifestyle component are intended to reinforce each other.

Finally, stress and sleep quality affect hunger hormones independently of any medicine. Someone going through a period of disrupted sleep or high cortisol may find appetite signals harder to reduce, regardless of dose. None of this means 5mg is useless; it means appetite suppression is one piece of a more complicated picture.

How the titration schedule is meant to work, and when patience is warranted

The licensed Mounjaro titration moves through doses in roughly four-week steps, guided by the prescriber. The logic is gradual dose-building to reduce the gastrointestinal side effects that can accompany faster escalation (nausea, stomach discomfort and similar) while allowing the body time to respond. You can read more about how each dose stage functions on the Mounjaro 5mg dose overview.

For many people, the step from 5mg to 7.5mg is where appetite suppression becomes more clearly noticeable. Others find it at 10mg. A minority feel it early, at 2.5mg or 5mg. The variation is real and documented. If you moved to 5mg from 2.5mg and also noticed little change at 2.5mg, that is a pattern worth discussing at your next clinical review rather than interpreting as treatment failure.

Patience here is not passive. Track your hunger patterns, note portion sizes and energy levels, and bring that information to your prescriber. A clear picture of your treatment progress helps your prescriber decide whether continuing at 5mg for another cycle, or moving to the next step, is the right clinical call. That decision belongs to them.

When to raise it, and what not to do in the meantime

If you reach the end of your current four-week period at 5mg without any reduction in appetite and without the early weight-change signal your prescriber would expect, that is worth flagging. It is not, however, a reason to increase your dose independently, take extra doses, or switch to another product without assessment.

Self-adjusting a prescription-only medicine carries real risks. Tirzepatide dose increases can intensify gastrointestinal side effects sharply if escalated too quickly, and the prescriber's role in managing that is not administrative box-ticking. At your review, your prescriber will weigh your response, your tolerance, and your overall health picture before recommending any change. If you are currently treated through nume, the clinical review before every repeat is precisely the moment to raise this, our prescribers will look at your progress and discuss the right next step with you.

In the meantime, keep the lifestyle foundations in place. Protein at each meal, adequate hydration, and consistent sleep all support the metabolic environment the medicine is working within. None of them replaces the appetite effect, but they prevent a missing appetite signal from being the only thing driving (or not driving) your results. If you have concerns about why hunger suppression can be limited at this stage of treatment, that is covered in more detail alongside the broader view of how the medicine works across the full titration in the Mounjaro treatment overview, which covers the licensed schedule in full.